Skip to main content
Bradley McGregor, MD, Oncology, Boston, MA

BradleyAlexanderMcGregorMD

Oncology Boston, MA

Genitourinary Oncology, Hematologic Oncology

Physician

Dr. McGregor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. McGregor's full profile

Already have an account?

  • Office

    450 Brookline Ave
    Boston, MA 02215
    Phone+1 617-632-6328

Summary

  • Dr. Bradley McGregor is an oncologist in Boston, MA and is affiliated with Dana-Farber Cancer Institute. He received his medical degree from Tufts University School of Medicine and has been in practice 13 years. He specializes in genitourinary oncology and hematologic oncology.

Education & Training

  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumFellowship, Hematology and Medical Oncology, 2007 - 2010
  • San Antonio Uniformed Services Health Education Consortium
    San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 2004 - 2007
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - Present
  • FL State Medical License
    FL State Medical License 2022 - Present
  • ME State Medical License
    ME State Medical License 2022 - 2026
  • OH State Medical License
    OH State Medical License 2022 - 2026
  • RI State Medical License
    RI State Medical License 2022 - 2026
  • CT State Medical License
    CT State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2016 - 2025
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell Carcinoma  
    Praful Ravi, Charlene Mantia, Christopher Su, Neeraj Agarwal, Yousef Zakharia, Rana R Mckay, Vivek Narayan, Ajjai Alva, Bradley A Mcgregor, David F Mcdermott, Toni K C..., JAMA Oncology

Lectures

  • Phase II study of nivolumab and ipilimumab for advanced bladder cancer of variant histologies (BCVH). 
    2019 ASCO Annual Meeting - 6/1/2019

Authored Content

  • Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
  • Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020

Press Mentions

  • Trial Finds No Benefit of Adding Nivolumab to Tivozanib for Advanced Kidney Cancer
    Trial Finds No Benefit of Adding Nivolumab to Tivozanib for Advanced Kidney CancerSeptember 14th, 2024
  • Fewer Adverse Effects with SBRT in Localized Prostate Cancer?
    Fewer Adverse Effects with SBRT in Localized Prostate Cancer?February 21st, 2023
  • Is a Diet Higher in Plant-Based Foods Associated with a Lower Risk of Prostate Cancer Progression and Recurrence?
    Is a Diet Higher in Plant-Based Foods Associated with a Lower Risk of Prostate Cancer Progression and Recurrence?February 17th, 2023
  • Join now to see all

Professional Memberships